Breed's Hill Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.16M Buy
1,484
+89
+6% +$69.2K 0.56% 30
2025
Q1
$1.15M Sell
1,395
-31
-2% -$25.8K 0.62% 29
2024
Q4
$1.1M Buy
1,426
+969
+212% +$802K 0.58% 28
2024
Q3
$405K Sell
457
-90
-16% -$80.9K 0.33% 49
2024
Q2
$495K Sell
547
-6
-1% -$4.8K 0.44% 41
2024
Q1
$430K Sell
553
-33
-6% -$23.5K 0.4% 43
2023
Q4
$342K Buy
+586
New +$342K 0.33% 49

Other funds holding LLY

Breed's Hill Capital's LLY Position: Q2 2025 in Review

Breed's Hill Capital increased its Eli Lilly (LLY) stake by 6.4% in Q2 2025, buying an estimated $69.2K and bringing the position to 1,484 shares worth $1.16M. The position accounts for 0.56% of the portfolio, ranked #30.

Breed's Hill Capital first reported a position in LLY in Q4 2023 and has held it in 7 quarters since. 3,914 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Breed's Hill Capital held 1,484 shares of Eli Lilly worth $1.16M as of Q2 2025.
  • Breed's Hill Capital bought 89 Eli Lilly shares in Q2 2025, an estimated $69.2K.
  • Eli Lilly made up 0.56% of Breed's Hill Capital's portfolio in Q2 2025, its #30 holding.
  • Breed's Hill Capital first reported a position in Eli Lilly in Q4 2023 and has held it in 7 quarters since.
  • 3,914 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Breed's Hill Capital's 13F filing for Q2 2025, filed 8 Aug 2025.